In vitro experiments demonstrate that LINC01929 promotes breast cancer cell proliferation and survival, with significant growth inhibition observed following LINC01929 knockdown, which emphasises its critical function in cell cycle regulation and paves the way for its potential use as a prognostic indicator or therapeutic target in personalised cancer treatment strategies. This evidence concerns the gene LINC01929 and breast cancer.